Changes Identified in Body Cells During Type2 Diabetes Onset
Researchers at Dublin City University and their project partners in the EU FP7 funded DEXLIFE project have found fresh evidence to explain the processes that occur in the body’s cells leading to the onset of type2 diabetes.
To date, the molecular mechanisms, underpinning, the development of type2 diabetes is not completely understood.
This new finding is important as it demonstrates what happens at a cellular level and how diabetes and insulin resistance occur.
The research has been published in the journal Scientific Reports.
The findings show that amino acids, the building blocks of cells, play a contributory role in the onset of type2 diabetes in some younger and older patients, as the metabolism of specific amino acids is adversely affected.
The study carried out tests on the skeletal muscles and plasma from older and younger patients with type2 diabetes.
It looked at a specific set of amino acids, called branched chained amino acids (BCCA).
Results found, that type2 diabetes patients showed an impaired expression of the genes involved in BCCA metabolism when compared to obese individuals without diabetes.
These results suggest that a change in the ability of the cell to process amino acids may be an important factor in the development of type2 diabetes.
Commenting on the findings Associate Professor, DCU, Donal O’Gorman, Interim Director of the National Institute for Cellular Biotechnology and Head of the 3U Diabetes Consortium said:
“This study underlines the importance of the EU FP7 collaborative research projects.
With our DEXLIFE partners we are able to offer a new insight into the pathophysiology of type 2 diabetes.
The detailed clinical, physiological and cellular investigations performed allow us to provide an explanation for our observations in patients.”
This article has been republished from materials provided by Dublin City University. Note: material may have been edited for length and content. For further information, please contact the cited source.
María Isabel Hernández-Alvarez, Angels Díaz-Ramos, María Berdasco, Jeff Cobb, Evarist Planet, Diane Cooper, Agnieszka Pazderska, Krzystof Wanic, Declan O’Hanlon, Antonio Gomez, Laura R. de la Ballina, Manel Esteller, Manuel Palacin, Donal J. O’Gorman, John J. Nolan, Antonio Zorzano. Early-onset and classical forms of type 2 diabetes show impaired expression of genes involved in muscle branched-chain amino acids metabolism. Scientific Reports, 2017; 7 (1) DOI: 10.1038/s41598-017-14120-6.
Watching Stem Cells Repair Spinal Cord in Real TimeNews
Clues to the reversal of brain and spine injury.READ MORE
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE